Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Asset Utilization Ratio (2016 - 2017)

Historic Asset Utilization Ratio for Soleno Therapeutics (SLNO) over the last 5 years, with Q1 2018 value amounting to 0.0.

  • Soleno Therapeutics' Asset Utilization Ratio fell 9994.05% to 0.0 in Q1 2018 from the same period last year, while for Mar 2018 it was 0.0, marking a year-over-year decrease of 9994.05%. This contributed to the annual value of 0.21 for FY2016, which is 18793.95% up from last year.
  • Latest data reveals that Soleno Therapeutics reported Asset Utilization Ratio of 0.0 as of Q1 2018, which was down 9994.05% from 0.01 recorded in Q4 2017.
  • Soleno Therapeutics' Asset Utilization Ratio's 5-year high stood at 0.15 during Q4 2016, with a 5-year trough of 0.82 in Q4 2014.
  • Moreover, its 5-year median value for Asset Utilization Ratio was 0.02 (2017), whereas its average is 0.08.
  • In the last 5 years, Soleno Therapeutics' Asset Utilization Ratio surged by 16050.52% in 2016 and then plummeted by 9994.05% in 2018.
  • Quarter analysis of 5 years shows Soleno Therapeutics' Asset Utilization Ratio stood at 0.82 in 2014, then surged by 109.58% to 0.08 in 2015, then surged by 95.14% to 0.15 in 2016, then tumbled by 94.69% to 0.01 in 2017, then tumbled by 99.67% to 0.0 in 2018.
  • Its Asset Utilization Ratio stands at 0.0 for Q1 2018, versus 0.01 for Q4 2017 and 0.02 for Q3 2017.